Thomas Swalla, CEO of Dotmatics, takes a look at how the power of data science can help aid in R&D innovations. At its core, science is about discovering hidden truths. Some of those truths are so ...

Thomas Swalla is CEO and board director at Dotmatics, leading a team of 800 mission-driven scientists and employees who are focused on helping scientists make the world a healthier, cleaner, safer ...

Scientific software specialist Dotmatics acquired M-Star, a computational fluid dynamics (CFD) software company headquartered outside of Baltimore. The deal, which marks the thirteenth acquisition by ...

Ten years and $2.5 billion — that’s what it takes, on average, to bring a new drug to market in the United States. Artificial intelligence promises to supercharge this process, drastically reducing ...

Artificial intelligence is making it quicker to get drug candidates to the clinic, but it isn’t addressing the fundamental need to marry the right candidate and the right target to the right disease.